From: PMS2 mutation spectra in Norway and risk of cancer for carriers of pathogenic variants
Class
Number (%)
Variants in
4–5
29 (13.2%)
Table 2
3 (VUS)
48 (21.8%)
Supplementary table S1
1–2
143 (65%)